Cargando…

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa

Under the Global Program to Eliminate Lymphatic Filariasis (LF) American Samoa conducted seven rounds of mass drug administration (MDA) between 2000 and 2006. Subsequently, the territory passed the WHO recommended school-based transmission assessment survey (TAS) in 2011/2012 (TAS-1) and 2015 (TAS-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemin, Morgan E., Cadavid Restrepo, Angela, Mayfield, Helen J., Lau, Colleen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609614/ https://www.ncbi.nlm.nih.gov/pubmed/36288036 http://dx.doi.org/10.3390/tropicalmed7100295

Ejemplares similares

Spatial predictive risk mapping of lymphatic filariasis residual hotspots in American Samoa using demographic and environmental factors
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2023)

Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2022)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods
por: Wangdi, Kinley, et al.
Publicado: (2022)

Supporting elimination of lymphatic filariasis in Samoa by predicting locations of residual infection using machine learning and geostatistics
por: Mayfield, Helen J., et al.
Publicado: (2020)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2021)

Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019
por: McPherson, Brady, et al.
Publicado: (2022)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
por: Coutts, Shaun P., et al.
Publicado: (2017)

Lymphatic filariasis epidemiology in Samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups
por: Lau, Colleen L., et al.
Publicado: (2020)

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019
por: Willis, Gabriela A., et al.
Publicado: (2023)

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
por: Graves, Patricia M., et al.
Publicado: (2021)

Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014
por: Graves, Patricia M., et al.
Publicado: (2020)

Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa
por: Shaw, Callum, et al.
Publicado: (2023)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
por: Lau, Colleen L., et al.
Publicado: (2017)

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018
por: Willis, Gabriela A., et al.
Publicado: (2020)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018)

Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
por: Schmaedick, Mark A., et al.
Publicado: (2014)

Leptospirosis, American Samoa
por: Lau, Colleen L., et al.
Publicado: (2012)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2018)

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing ‘number needed to test’ by targeting older age groups, hotspots, and household members of infected persons
por: Lau, Colleen L., et al.
Publicado: (2020)

Leptospirosis in American Samoa – Estimating and Mapping Risk Using Environmental Data
por: Lau, Colleen L., et al.
Publicado: (2012)

Seroprevalence of Dengue in American Samoa, 2010
por: Duncombe, Jennifer, et al.
Publicado: (2013)

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa
por: Ah Leong-Lui, Tile A., et al.
Publicado: (2019)

Environmental suitability for lymphatic filariasis in Nigeria
por: Eneanya, Obiora A., et al.
Publicado: (2018)

The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
por: Kimura, Eisaku
Publicado: (2011)

Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia — American Samoa, 2019
por: Hast, Marisa A., et al.
Publicado: (2020)

Emergence of new leptospiral serovars in American Samoa - ascertainment or ecological change?
por: Lau, Colleen L, et al.
Publicado: (2012)

Implications of a travel connectivity-based approach for infectious disease transmission risks in Oceania
por: Cadavid Restrepo, Angela, et al.
Publicado: (2021)

A Synthetic Population for Modelling the Dynamics of Infectious Disease Transmission in American Samoa
por: Xu, Zhijing, et al.
Publicado: (2017)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Origin, Impact, and Solutions for Lifestyle-Related Chronic Diseases in Samoa and American Samoa
por: Neuendorf, Sable, et al.
Publicado: (2021)

The geographical distribution of lymphatic filariasis infection in Malawi
por: Ngwira, Bagrey MM, et al.
Publicado: (2007)

Modelling Co-Infection with Malaria and Lymphatic Filariasis
por: Slater, Hannah C., et al.
Publicado: (2013)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Spatial variation in lymphatic filariasis risk factors of hotspot zones in Ghana
por: Kwarteng, Efiba Vidda Senkyire, et al.
Publicado: (2021)

Mapping, Bayesian Geostatistical Analysis and Spatial Prediction of Lymphatic Filariasis Prevalence in Africa
por: Slater, Hannah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ccm56doarqb7ckjs3j09psljd2